Sanquin Research & Blood Bank Divisions
19
1
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
10.5%
2 terminated/withdrawn out of 19 trials
81.8%
-4.7% vs industry average
47%
9 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Bleeding Disorder of Unknown Cause in the Netherlands
Role: collaborator
PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia
Role: collaborator
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
Role: collaborator
Transfusion Effects in Myelodysplastic Patients: Limiting Exposure
Role: lead
Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.
Role: collaborator
Towards Routine HPA-screening In Pregnancy to Prevent FNAIT
Role: collaborator
Assessment of the Mu-Drop System for Serum Eye Drops
Role: lead
Data Registry of Auto Immune Hemolytic Anemia
Role: lead
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
Role: lead
Allogeneic Versus Autologous Serum Eye Drops
Role: lead
Pathogen Reduction Evaluation & Predictive Analytical Rating Score
Role: lead
Clinical Trial for Fibrin Sealant in Knee Surgery
Role: lead
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
Role: lead
Well Being of Obstetric Patients on Minimal Blood Transfusions
Role: lead
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
Role: lead
Blood Management in Orthopedic Surgery
Role: lead
Collection of Autologous Blood Products by Double Erythrocytapheresis
Role: lead
Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)
Role: collaborator
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
Role: lead
All 19 trials loaded